ReviewSARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
Graphical abstract
Keywords
SARS-CoV-2
COVID-19
Cardiovascular
ACE2
Cytokine storm
Abbreviations
ACE
Angiotensin-converting enzyme
Ang
Angiotensin
ARB
Angiotensin receptor blocker
ARDS
Acute respiratory distress syndrome
CAD
Coronary artery disease
COVID-19
Coronavirus disease 2019
CVD
Cardiovascular diseases
DIC
Disseminated intravascular coagulation
ECMO
Extracorporeal membranous oxygenation
HFpEF
Heart failure with preserved ejection fraction
ICU
Intensive care unit
IFN
Interferon
IL
Interleukin
IP-10
Interferon -γ inducible protein 10
MCP-1
monocyte chemoattractant protein 1
MERS
Middle East respiratory syndrome
MOF
Multiple organ failure
NT-proBNP
N-terminal pro-brain natriuretic peptide
RAAS
Renin-angiotensin-aldosteron system
RDRP
RNA-dependent RNA polymerase proteins
ROS
reactive oxygen species
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
TNF
Tumor necrosis factor
Cited by (0)
- 1
Equal contribution.
© 2020 Elsevier Inc. All rights reserved.